Ongoing Special Issues
Focused clinical collections curated by world-leading oncology and hematology experts.
Sanford Burnham Prebys Medical Discovery Institute, United States
Non-Hodgkin Lymphomas represent a complex spectrum of malignancies requiring interdisciplinary solutions. This special issue aims to bring together professionals to showcase the most recent developments in research and encourage the exchange of knowledge. A specific emphasis is placed on "Diffuse Large B-Cell Lymphoma (DLBCL)," focusing on immunity and novel curative pathways.
- Molecular Markers
- Clinical Epidemiology
- Genetics & Epigenetics
- Novel Drug Discovery
- Advanced Cancer Therapy
- Multidisciplinary Care
- Oncology Surgery
- Diagnostic Radiology
- Hematopathology
- Medical Imaging
- Quality of Life
- Psychosocial Support
Recognized Expert in Molecular Oncology
Breast cancer remains a leading global health challenge, with 2.3 million women diagnosed in 2022. This issue explores the transition from traditional chemotherapy to personalized molecular medicine. We invite original papers focusing on high-quality clinical research that addresses the strikings disparities in the burden of breast cancer according to human development levels.
- Heterogeneity in Breast Cancer
- Genetic & Epigenetic Disorders
- Molecular Biology of BC
- ESR1 Mutations
- Targeted Therapeutic Agents
- Novel Immunotherapies
- Personalized Treatment Plans
- Life Expectancy & Quality of Life
Editor's Vision: Modern drugs with varied mechanisms of action are essential to slow progression and minimize symptoms. This issue facilitates the search for new targets that will significantly increase treatment effectiveness across diverse global populations.
Advancing clinical outcomes through specialized knowledge. Last updated: January 2026.
